Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Numerous cancer drugs have received accelerated approval from the US Food and Drug Administration (FDA) based on clinical trial outcomes that are otherwise not acceptable for traditional FDA approval; the accelerated approval process allows outcomes based on surrogate measures that are only reasonab...

Celý popis

Podrobná bibliografia

Vydané v:	JAMA internal medicine Ročník 181; číslo 4; s. 490
Hlavní autori:	Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S, Gyawali, Bishal, Mossialos, Elias
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.04.2021
Predmet:	Antineoplastic Agents - economics Cohort Studies Drug Approval Humans Insurance Coverage State Medicine
ISSN:	2168-6114, 2168-6114
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!